Fingerprint Verification
Verified Clinical Trials (VCT) offers an optional biometric fingerprint verification technology—a first-of-its-kind solution purpose-built for clinical research. This system provides a powerful safeguard against professional and duplicate research subjects, ensuring that only eligible participants advance at the time of screening.
VCT’s fingerprint verification technology:
Prevents fake or fraudulent IDs
Improves speed and accuracy, reducing manual entry and transcription errors
Operates with complete privacy protection — VCT never collects or stores actual fingerprints; instead, a proprietary encrypted template is generated and securely matched for each verification event
Is simple, fast, and cost-effective to implement at any site
As an optional enhancement, biometric fingerprint verification adds another layer of sensitivity and specificity to the VCT process—further improving subject validation, data integrity, and overall study quality.
Facial Recognition (In Development)
VCT is advancing its next-generation facial recognition biometric platform, designed for use in both traditional site-based and decentralized or virtual clinical trials.
This technology will allow secure and seamless remote identity verification using a smartphone, tablet, or computer—ideal for studies with limited on-site visits. By integrating facial recognition, VCT will further accelerate verification speed and precision, strengthening protections across all study models.
Global Compliance
All of VCT’s biometric technologies are fully compliant with international data privacy and security regulations. They are designed to operate safely and effectively in nearly every global jurisdiction, helping sponsors, CROs, and sites protect both participants and study integrity.
Together, VCT’s biometric fingerprint and facial recognition systems represent the most advanced verification framework in the industry—empowering sites with unmatched accuracy, efficiency, and compliance while preventing professional and duplicate subjects from compromising your clinical trial.